Spectrophotometric Determination of Escitalopram in Pharmaceuticals
DOI:
https://doi.org/10.7439/ijpc.v2i4.773Abstract
A new, simple, fast and sensitive two spectrophotometric methods has been developed for determination of Escitalopram in bulk and tablet dosage forms. The method A is based on the oxidation of Escitalopram by a known excess of bromate-bromide mixture in hydrochloric acid medium, reduction of the residual oxidant by a fixed amount of iron(II) and the formation of iron(III)-thiocyanate-complex which is measured at 480 nm. In the method B, 1,10-phenanthroline is used as a complexing agent and the formation of iron(II)-1,10-phenanthroline, which is measured at 510 nm.Downloads
Downloads
Published
2013-01-01
Issue
Section
Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
- The author must submit Copyright form After acceptance of the article.
How to Cite
1.
Spectrophotometric Determination of Escitalopram in Pharmaceuticals. Int J of Pharm Chem [Internet]. 2013 Jan. 1 [cited 2025 Jun. 8];2(4):121-5. Available from: https://ssjournals.co.in/index.php/ijpc/article/view/1296
